State aid probe into Dexia extended–Comm’n concerned with the orderly resolution plan
The European Commission is extending its in-depth investigation into recapitlization and guarantees granted to Dexia in 2008 and 2009 by France, Belgium and Luxembourg The probe is extended to September 30, 2012 so that the Commission may examine the orderly resolution plan of the bank that was submitted by the three countries in March of this year. Until then, the Commission approves extending the temporary gurantee of €45 billion for Dexia granted by the Member states that was set to expire on May 31.
Under the orderly resolution plan, Dexia Municipal Agency will be sold to the French State as a going concern. However, the Commission is concerned that the aid will be used to perpetuate the ongoing existence of what is a failed business model. The Commission is also concerned with the fact that remuneration under the orderly resolution plan is close to zero. In addition, the Commission will be taking a closer look at Arcofin’s contribution to Dexia recapitalization.
Full content: EC Press Release
Related content: Stability and Competition in EU Banking During the Financial Crisis: The Role of State Aid Control (Gert-Jan Koopman, DG Comp)
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas